Just the mention of getting the R/S "re-aurthorised " so that the BOD can run things is enough to send this stock spiralling, just look at the last 2 weeks since the Proxy went out.
Usually penny stocks mask their reasons for the split behind an uplisting attempt or making the stock more attractive to institutional inventors.
In order for TOMDF to achieve this, either they would need to do a 200 to 1 r/s for the NasDaq or at minimum a 25 to 1 to attract institutional investors.
Either way there are often other reasons for the split. With 1,200,000,000 outstanding shares it is likely the co would love to bring that down so that they can start building it up again.
Outside Investors also like to see at least 50 cents after the split so that they can set benchmark loans, tranches, and have room to hedge their investment/loan in other ways.
The Pharma sector was hot but has been dead for almost 2 years. TOMDF or actually 3CL Pharma would have to do a huge public relations promo for their CrowdFunding scheme then follow that up with a string of excellent new press releases to keep the interest going to sustain the TOMDF shareprice.
On top of all that when a company artificially raises it's shereprice it has further to fall and opens itself to ruthless investors like shorters and hedgefunds betting, on the odds, that the consolidation will fail. Often even the Lenders will prevail once the shareprice falls and money is tight and milestones don't get met
It's a tragedy and history shows that share consolidations in penny and micropenny stocks will fail but some others will make money either way
News 
Market Data 
Discover 
AI
